Sigachi Industries Share Price Rises After New R&D Center Launch in Hyderabad

Market Performance

The share price of Sigachi Industries witnessed a modest uptick in early trade on Wednesday, June 18, following a significant corporate development.

• The stock opened at ₹54.90 per share, up from the previous close of ₹54.72
• It reached an intraday high of ₹55.62 in early trading
• However, it later dipped to an intraday low of ₹54.52

This fluctuation in Sigachi Industries' share price came in the wake of a significant strategic announcement by the company.

Main News: New R&D Center Unveiled in Hyderabad

Sigachi Industries has officially launched a new Research & Development (R&D) Center in Hyderabad, marking a strategic milestone for the company's growth trajectory.

The newly inaugurated facility is tailored to boost the development of critical Active Pharmaceutical Ingredients (APIs) and improve the company's internal analytical capabilities. The advanced center is part of Sigachi's plan to strengthen innovation and enhance compliance with global pharmaceutical standards.

Company Details: Focused Investment and Future-Ready Facility

According to the official statement issued on June 18, the R&D Center in Hyderabad is poised to become a cornerstone for Sigachi Industries' innovation efforts and regulatory compliance initiatives.

Key Highlights of the New R&D Facility:

• Investment: Up to USD 1 million targeted towards high-priority APIs and complex intermediates
• Capabilities: Integration of advanced systems for synthesis, analytics, and regulatory filings
• Portfolio Strategy: Realignment of the pharma portfolio toward key therapeutic areas
• Research Team: Empowerment of a dedicated team to lead product development for global markets

The company's Managing Director and CEO, Amit Raj Sinha, described the R&D center as a "strategic asset" poised to add long-term value for stakeholders and partners.

Summary

Sigachi Industries' share price experienced early gains on Wednesday after the company announced the inauguration of a cutting-edge R&D Center in Hyderabad. With an investment commitment of up to USD 1 million, the facility aims to reinforce API development and global regulatory alignment. This development reflects Sigachi's commitment to innovation, operational excellence, and international market competitiveness in the pharmaceutical sector.